Avance Clinical Contracted for Atossa Therapeutics AT-301 Nasal Spray Clinical Study, Atossa's Second COVID-19 Therapeutic Development Program
- Written by ACN Newswire - Press Releases
Read more //?#
.
Australia’s Young Entrepreneurs Redefining Success Through Legacy and Community Impact
A new generation of young Australian small business owners is redefining success, driven by a desire to create a lasting legacy through the positi...
Lessons in AI: How LoanOptions.ai Shows What Smart Adoption Really Looks Like
In a world where many small businesses are still trying to work out how to actually use AI (not just talk about it), Australian fintech LoanOption...
Driving smarter: how car subscription models are redefining mobility and financial flexibility
The world of mobility is changing fast, and car ownership is no longer the default. Across Australia, professionals and businesses alike are seeki...
The Future of Wealth Technology
“You shouldn’t need a large account balance to experience real-time investing. Technology should make that kind of access universal.” For decades...
Thryv wins national accolade at 2025 Australian Service Excellence Awards
Thryv® (NASDAQ: THRY), Australia’s provider of the leading small business marketing and sales software platform, announced that Greg Nicolle, G...
pay.com.au unveils first-of-its-kind FX rewards feature, becoming the most flexible rewards solution for Aussie businesses
pay.com.au, the end-to-end payments and rewards platform, today announced the launch of International Payments, Australia’s first foreign exchange...